Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. DPOH name: ARANCIBIA, RODRIGO
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (118)
Results: 1-50 | Export
  1. Sandoz Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-04-10
    Posted: 2024-04-15
    Designated public office holders:
    • Rodrigo Arancibia, Senior Director, Department of industry | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
    • Health
    • Industry
      •
  2. Bruce Power
    Type: In-house Corporation
    Occurred: 2024-03-26
    Posted: 2024-04-15
    Designated public office holders:
    • Mitchell Rowe, Senior Policy Analyst, Office of Pharmaceuticals Management | Health Canada (HC)
    • Samir Khan, Director, Office of Pharmaceuticals Management | Health Canada (HC)
    • Denis Arsenault, Manager of Policy Development, Health Products and Food Branch | Health Canada (HC)
    • Dr. Michael Rosu-Myles, Director, Biological and Radiopharmaceutical Drugs | Health Canada (HC)
    • Cameron Christensen, Senior Investment Analyst, Collaborations and Net Office of Life Sciences and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Sciences, Office of Life Sciences and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    • Mary Boreskie, Sector Analyst, Life Sciences Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Malcolm McEwen, Director, Research and Development, Energy, Mining, and Environment | National Research Council (NRC)
    • Raphael Galea, Team Leader, Metrology | National Research Council (NRC)
    • Kate Prosser, Policy Advisor, Uranium and Radioactive Waste Division | Natural Resources Canada (NRCan)
    • Tess Wittman, Policy Analyst, Uranium and Radioactive Waste Division | Natural Resources Canada (NRCan)
    • Pui Wai Yuen, Director, Uranium and Radioactive Waste Division | Natural Resources Canada (NRCan)
    • Frédéric Beauregard-Tellier, Director General, Nuclear Energy and Infrastructure Security Branch | Natural Resources Canada (NRCan)
    Subject matters:
    • Energy
    • Health
    • Research and Development
      •
  3. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-02-15
    Posted: 2024-03-13
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
    • Research and Development
    • Industry
      •
  4. Praxis Spinal Cord Institute / Praxis Institut de la moelle épinière
    Type: In-house Organization
    Occurred: 2024-02-12
    Posted: 2024-03-04
    Designated public office holders:
    • Jean-Philippe Lapointe, Director General, Strategic Innovation Fund | Innovation, Science and Economic Development Canada (ISED)
    • Eric Bourbonnais, Director, Strategic Innovation Fund-Business Development and Strategy Branch | Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee, Assistant Deputy Minister, Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Sciences Industries, Office of Life Sciences and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Research and Development
    • Health
    • Science and Technology
      •
  5. JN Nova Pharma Inc.
    Type: Consultant
    Lobbyist: Stephen Sampson, Global Public Affairs
    Occurred: 2024-02-12
    Posted: 2024-02-13
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Sciences Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee, Assistant Deputy Minister, Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
    • Health
    • Research and Development
    • Industry
    • Intellectual Property
      •
  6. AbCellera Biologics Inc.
    Type: In-house Corporation
    Occurred: 2024-02-07
    Posted: 2024-03-15
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee, Assistant Deputy Minister, Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
      •
  7. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-02-07
    Posted: 2024-03-15
    Designated public office holders:
    • Ritu Banerjee, Assistant Deputy Minister, Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director for Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
      •
  8. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-01-23
    Posted: 2024-02-15
    Designated public office holders:
    • Benoit Leduc, Manager | Innovation, Science and Economic Development Canada (ISED)
    • Caroline Menard, Manager, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee, Assistant Deputy Minister, Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  9. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-11-14
    Posted: 2023-12-15
    Designated public office holders:
    • Ritu Banerjee, Assistant Deputy Minister, Office of Life Science and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Office of Life Science and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Research and Development
    • Health
      •
  10. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2023-11-01
    Posted: 2023-12-15
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
      •
  11. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2023-10-25
    Posted: 2023-11-15
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
      •
  12. Hoffmann-La Roche Limited
    Type: In-house Corporation
    Occurred: 2023-10-24
    Posted: 2023-11-14
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  13. Hoffmann-La Roche Limited
    Type: In-house Corporation
    Occurred: 2023-10-16
    Posted: 2023-11-14
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  14. Hoffmann-La Roche Limited
    Type: In-house Corporation
    Occurred: 2023-10-12
    Posted: 2023-11-14
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  15. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2023-09-29
    Posted: 2023-10-16
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
      •
  16. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2023-09-20
    Posted: 2023-10-16
    Designated public office holders:
    • Joel Denis, Director General, Vaccine Supply and Assurance | Public Health Agency of Canada (PHAC)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General, Biomanufacturing Strategy Implementation Team | Innovation, Science and Economic Development Canada (ISED)
    • Kasondra White, Director, Office of Life Sciences and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
    • Health
      •
  17. Hoffmann-La Roche Limited
    Type: In-house Corporation
    Occurred: 2023-09-20
    Posted: 2023-10-15
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Heather Earle, Manager, OLSBR | Innovation, Science and Economic Development Canada (ISED)
    • Lynn Berrouard, Senior Analyst, OLSBR | Innovation, Science and Economic Development Canada (ISED)
    • Ryan Sigouin, Manager | Health Canada (HC)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Christopher Johnstone, Assistant Deputy Minister, Covid-19 Task Force | Health Canada (HC)
    • Kasondra White, Director of Strategy | Innovation, Science and Economic Development Canada (ISED)
    • Joel Denis, Director General | Public Health Agency of Canada (PHAC)
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  18. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2023-09-13
    Posted: 2023-10-16
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Economic Development
      •
  19. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-09-05
    Posted: 2023-10-11
    Designated public office holders:
    • Ritu Banerjee, Assistant Deputy Minister, Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Research and Development
    • Health
    • Economic Development
      •
  20. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2023-07-31
    Posted: 2023-08-15
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Economic Development
      •
  21. Vertex Pharmaceuticals (Canada) Incorporated
    Type: In-house Corporation
    Occurred: 2023-07-04
    Posted: 2023-08-15
    Designated public office holders:
    • caroline menard, manager | Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee, Assistant Deputy Minister, Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
    • Research and Development
    • Health
      •
  22. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2023-06-26
    Posted: 2023-07-15
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
      •
  23. Centre for the Commercialization of Regenerative Medicine / Centre de commercialisation de la médecine régénérative
    Type: Consultant
    Lobbyist: WILLIAM MANTEL
    Occurred: 2023-06-16
    Posted: 2023-07-15
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
    • Research and Development
    • Science and Technology
      •
  24. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-06-06
    Posted: 2023-07-15
    Designated public office holders:
    • Rodrigo Arancibia, Director for Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
    • Andy Fillmore, Member of Parliament, Parliamentary Secretary to the Minister of Innovation, Science and Industry | House of Commons
    Subject matters:
    • Economic Development
      •
  25. Merck Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-06-06
    Posted: 2023-07-12
    Designated public office holders:
    • ritu Banerjee, Assistant deputy Minister, Life Science & Biomanufacturing Branch | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
    • Research and Development
    • Industry
      •
  26. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2023-06-06
    Posted: 2023-07-15
    Designated public office holders:
    • Darryl Patterson, Director General, Biomanufacturing Strategy Implementation Team | Innovation, Science and Economic Development Canada (ISED)
    • Andy Fillmore, Member of Parliament | House of Commons
    • Ritu Banerjee, Assistant Deputy Minister, Office of Life Sciences and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
    • Health
      •
  27. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2023-05-01
    Posted: 2023-06-15
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Economic Development
      •
  28. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2023-03-31
    Posted: 2023-04-03
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
      •
  29. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-03-29
    Posted: 2023-04-15
    Designated public office holders:
    • Razan Shahin, Manager, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Caroline Menard, Manager, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Research and Development
      •
  30. GlaxoSmithKline Consumer Healthcare ULC
    Type: Consultant
    Lobbyist: Ashley Brambles, Edelman Global Advisory / Ashley M Brambles
    Occurred: 2023-03-09
    Posted: 2023-04-15
    Designated public office holders:
    • Rouben Khatchadourian, Vice President, Strategic Support | Public Health Agency of Canada (PHAC)
    • Rodrigo Arancibia, Director for Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Agriculture
    • Science and Technology
      •
  31. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2023-02-16
    Posted: 2023-03-15
    Designated public office holders:
    • Caroline Menard, Manager, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Benoit Leduc, Manager, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Economic Development
      •
  32. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2023-01-30
    Posted: 2023-02-15
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
      •
  33. AstraZeneca Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-01-26
    Posted: 2023-02-15
    Designated public office holders:
    • Rodrigo Arancibia, Director for Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
    • Craoline Menard, Manager | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
      •
  34. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2023-01-26
    Posted: 2023-02-15
    Designated public office holders:
    • Jean-Pierre Mizero, Manager, Integration, Outreach & Partnerships, Strategic Innovation Fund | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Alison McConnell, Deputy Director, Innovation Projects Directorate, Strategic Innovation Fund | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
      •
  35. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2023-01-24
    Posted: 2023-02-15
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
      •
  36. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2023-01-03
    Posted: 2023-02-15
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Research and Development
    • Economic Development
      •
  37. BioCanRx
    Type: Consultant
    Lobbyist: Kristina Proulx, Temple Scott Associates Inc.
    Occurred: 2022-11-03
    Posted: 2022-12-14
    Designated public office holders:
    • Maya Farhat, Manager, Science and Research Sector | Innovation, Science and Economic Development Canada (ISED)
    • Eric Costen , Senior Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Heather Earle, Manager | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Robbyn Plumb, Senior Director, Strategic Science Fund | Innovation, Science and Economic Development Canada (ISED)
    • Daniel Quinn, Director, Science and Research Sector | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
    • Budget
    • Research and Development
      •
  38. Centre for the Commercialization of Regenerative Medicine / Centre de commercialisation de la médecine régénérative
    Type: Consultant
    Lobbyist: WILLIAM MANTEL
    Occurred: 2022-10-14
    Posted: 2022-11-15
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn, Acting Director, Innovation Projects Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Research and Development
    • Economic Development
    • Science and Technology
      •
  39. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2022-09-20
    Posted: 2022-09-20
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
      •
  40. Centre for the Commercialization of Regenerative Medicine / Centre de commercialisation de la médecine régénérative
    Type: Consultant
    Lobbyist: WILLIAM MANTEL
    Occurred: 2022-09-13
    Posted: 2022-10-15
    Designated public office holders:
    • Eric Costen, Assistant Deputy Minister, Policy | Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn, Acting Director, Innovation Projects Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Alison McConnell, Deputy Director, Biomanufacturing Strategy Implementation Team | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
    • Research and Development
    • Science and Technology
      •
  41. Centre for the Commercialization of Regenerative Medicine / Centre de commercialisation de la médecine régénérative
    Type: Consultant
    Lobbyist: WILLIAM MANTEL
    Occurred: 2022-09-01
    Posted: 2022-10-15
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn, Acting Director, Innovation Projects Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
    • Research and Development
    • Economic Development
    • Regional Development
      •
  42. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-08-25
    Posted: 2022-09-15
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Eric Costen, Senior Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  43. Becton Dickinson Canada Inc
    Type: In-house Corporation
    Occurred: 2022-08-15
    Posted: 2022-09-12
    Designated public office holders:
    • roopa prihar, Policy Analyst | Innovation, Science and Economic Development Canada (ISED)
    • Andrea Adamson, Regional Regulatory Compliance and Enforcement Specialist, Regulatory | Health Canada (HC)
    • Rodrigo Arancibia , Director for Innovation, Science and Economic Development Canada | Innovation, Science and Economic Development Canada (ISED)
    • Nadine Bourdeau, Regional Regulatory Compliance and Enforcement Specialist, Regulatory | Health Canada (HC)
    • Aziz Haddad, Biomedical Engineer, Regulatory | Health Canada (HC)
    • Michael Collins, Director General, COVID-19 Taskforce | Health Canada (HC)
    • Kassondra Tyers, Analyst | Statistics Canada (StatCan)
    • Eric Bourbonnais, Associate Director | Innovation, Science and Economic Development Canada (ISED)
    • Sheryl Groeneweg, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Grace Chen, Advisor, Regulatory | Health Canada (HC)
    • Kate Cavallaro, Manager | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  44. Applied Pharmaceutical Innovation
    Type: In-house Organization
    Occurred: 2022-06-20
    Posted: 2022-07-13
    Designated public office holders:
    • Jocelyn Milburn, Director | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
    • Education
    • Science and Technology
    • Employment and Training
    • Health
    • Research and Development
      •
  45. Applied Pharmaceutical Innovation
    Type: In-house Organization
    Occurred: 2022-06-15
    Posted: 2022-07-13
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
    • Education
    • Research and Development
    • Employment and Training
    • Science and Technology
    • Health
      •
  46. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-06-13
    Posted: 2022-06-19
    Designated public office holders:
    • Darryl Patterson, Director General, Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Industry
      •
  47. STEMCELL Technologies Canada Inc.
    Type: Consultant
    Lobbyist: Keith Serry, Keith Serry Counsel
    Occurred: 2022-06-07
    Posted: 2022-07-15
    Designated public office holders:
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn, Assistant Director, Life Sciences and Biomanufacturing Branch | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Taxation and Finance
    • Health
    • Economic Development
    • Research and Development
    • Science and Technology
      •
  48. STEMCELL Technologies Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-06-07
    Posted: 2022-07-15
    Designated public office holders:
    • Jocelyn Milburn, Assistant Director | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
    • Science and Technology
    • Health
    • Taxation and Finance
    • Research and Development
      •
  49. STEMCELL Technologies Canada Inc.
    Type: Consultant
    Lobbyist: Keith Serry, Keith Serry Counsel
    Occurred: 2022-05-31
    Posted: 2022-06-15
    Designated public office holders:
    • Amber Mousseau, Director | Innovation, Science and Economic Development Canada (ISED)
    • Alison McConnell, Manager | Innovation, Science and Economic Development Canada (ISED)
    • Eric Costen, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director | Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn, Assistant Director | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Science and Technology
    • Research and Development
    • Taxation and Finance
    • Economic Development
      •
  50. STEMCELL Technologies Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-05-31
    Posted: 2022-06-15
    Designated public office holders:
    • Amber Mousseau, Director | Innovation, Science and Economic Development Canada (ISED)
    • Eric Costen, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn, Assistant Director | Innovation, Science and Economic Development Canada (ISED)
    • Alison McConnell, Manager | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Economic Development
    • Taxation and Finance
    • Health
    • Science and Technology
    • Research and Development
      •
Date Modified: